You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

quetiapine XR

Showing 1 - 25 of 698
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Seoul (Lurasidone HCL 160 mg, Quetiapine XR 600 mg)

Active, not recruiting
  • Schizophrenia
  • Lurasidone HCL 160 mg
  • Quetiapine XR 600 mg
  • Seoul, Seoul, Dongjak-gu, Korea, Republic of
    Borame Medical Center
Jul 19, 2022

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)

Completed
  • Depressive Disorder, Major
  • Esketamine 28 mg
  • +6 more
  • Ciudad Autonoma de Buenos Aires, Argentina
  • +170 more
Sep 13, 2022

Depressive Disorder, Major Trial in Worldwide (Seltorexant, Matching to Seltorexant, Quetiapine XR)

Recruiting
  • Depressive Disorder, Major
  • Birmingham, Alabama
  • +212 more
Jul 20, 2022

Bipolar Disorder Therapies

Completed
  • Bipolar Disorder
  • Lithium Carbonate
  • +29 more
  • Albuquerque, New Mexico
    Christophe G Lambert
Sep 29, 2021

Depressive Disorder, Major Trial (Quetiapine 50 MG Extended Release Oral Tablet, Quetiapine Fumarate XR 150-300 mg, Placebos)

Completed
Has Results
  • Depressive Disorder, Major
  • Quetiapine 50 MG Extended Release Oral Tablet
  • +2 more
  • (no location specified)
Nov 14, 2019

Schizophrenia Trial in Worldwide (SEP363856, quetiapine XR)

Active, not recruiting
  • Schizophrenia
  • Cerritos, California
  • +45 more
Feb 16, 2022

MDD Trial in Hokkaidou, Kantou, Kinki (quetiapine extended release (XR), Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • quetiapine extended release (XR)
  • Placebo
  • Hokkaidou, Japan
  • +2 more
Jul 19, 2019

Multiple Sclerosis Trial in Calgary (Extended-release quetiapine fumarate)

Completed
  • Multiple Sclerosis
  • Extended-release quetiapine fumarate
  • Calgary, Alberta, Canada
    MS Clinic, Foothills Medical Centre
Oct 6, 2019

Treatment Resistant Depression Trial in Bhubaneswar (Quetiapine, Amantadine, Pramipexole)

Not yet recruiting
  • Treatment Resistant Depression
  • Bhubaneswar, Orissa, India
    All India Institute of Medical Sciences
Jun 26, 2021

Schizophrenia, Schizoaffective Disorder Trial in Long Beach (Lu AF35700 (10 mg/day), Lu AF35700 (30 mg/day), Quetiapine

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • Lu AF35700 (10 mg/day)
  • +2 more
  • Long Beach, California
    US1104
Sep 11, 2019

Psychiatric Disorders, Insomnia Trial in Copenhagen NV (Melatonin, Quetiapine, Placebo)

Recruiting
  • Psychiatric Disorders
  • Insomnia
  • Copenhagen NV, Denmark
    Mental Health Center Copenhagen
Sep 25, 2023

Delirium Trial in Cairo (Quetiapine)

Recruiting
  • Delirium
  • Cairo, Egypt
    Ain shams university hospitals
Apr 5, 2023

Alcoholism, Alcohol Abuse Trial in United States (Quetiapine fumarate, Placebo)

Completed
Has Results
  • Alcoholism
  • Alcohol Abuse
  • Quetiapine fumarate
  • Placebo
  • Boston, Massachusetts
  • +6 more
Feb 26, 2019

Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

Not yet recruiting
  • Opiate Withdrawal Syndrome
  • Opioid Use
  • Philadelphia, Pennsylvania
    University of Pennsylvania, Treatment Research Center
Aug 18, 2023

Delirium Trial in Cairo (Quetiapine)

Recruiting
  • Delirium
  • Cairo, Egypt
    Ain Shams University
Mar 30, 2023

Alcohol Dependence Trial in Bedford, Hanover (Mirtazapine, Quetiapine fumarate extended release (Quetiapine XR))

Completed
Has Results
  • Alcohol Dependence
  • Mirtazapine
  • Quetiapine fumarate extended release (Quetiapine XR)
  • Bedford, New Hampshire
  • +1 more
Mar 12, 2018

Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable

Not yet recruiting
  • Opioid-Related Disorders
  • +2 more
  • Injectable extended-release buprenorphine
  • Sublingual buprenorphine-naloxone
  • Garberville, California
  • +5 more
Aug 28, 2023

Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

Completed
  • Opioid-use Disorder
  • Extended release naltrexone
  • Loerenskog, Akershus, Norway
    Akershus University Hospital
Nov 30, 2022

Sacroiliitis Trial (High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR)

Not yet recruiting
  • Sacroiliitis
  • High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
  • (no location specified)
Sep 21, 2023

Korean Post-marketing Surveillance for Xeljanz XR

Recruiting
  • Active Moderate to Severe Rheumatoid Arthritis
  • Active Ankylosing Spondylitis
  • Tofacitinib XR
  • Seoul, Korea, Republic of
    Pfizer
Oct 10, 2022

Hyperactive Delirium Trial in Alexandria (Quatiapine, Haloperidol)

Recruiting
  • Hyperactive Delirium
  • Alexandria, Egypt
    Faculty of Medicine, Alexandria University Hospitals
Jan 17, 2023

JOURNEY II XR Safety and Effectiveness PMCF

Active, not recruiting
  • Rheumatoid Vasculitis With Rheumatoid Arthritis of Knee
  • +5 more
  • JOURNEY II XR Total Knee System
  • Loma Linda, California
  • +13 more
Sep 13, 2022

Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,

Completed
  • Healthy Volunteer
  • Dapagliflozin/metformin XR FDC 5/500 mg
  • +3 more
  • Suzhou, China
    Research Site
Apr 25, 2022